Literature DB >> 22433766

Learning effects in time trade-off based valuation of EQ-5D health states.

Liv Ariane Augestad1, Kim Rand-Hendriksen, Ivar Sønbø Kristiansen, Knut Stavem.   

Abstract

OBJECTIVES: In EuroQol five-dimensional questionnaire valuation studies, each participant typically assesses more than 10 hypothetical health states by using the time trade-off (TTO) method. We wanted to explore potential learning effects when using the TTO method, that is, whether the valuations were affected by the number of previously rated health states (the sequence number).
METHODS: We included 3773 respondents from the US EQ-5D valuation study, each of whom valued 12 health states (plus unconscious) in random order. With linear regression, we used sequence number to predict mean and standard deviations across all health states. We repeated the analysis separately for TTO responses indicating a state better than death and a state worse than death. Each TTO value requires a specific number of choice iterations. To test whether respondents used fewer iterations with experience, we used linear regression with sequence number as the independent variable and number of iterations as the dependent variable.
RESULTS: Mean TTO values were fairly stable across the sequence number, but analyzing state better than death and state worse than death values separately revealed a tendency toward more extreme values: state better than death values increased by 0.02, while state worse than death values decreased by 0.21 (P < 0.0001) over the full sequence. The standard deviations increased slightly, while the number of choice iterations was the same over the sequence number. The findings were stable across the levels of health state severity, age, and sex.
CONCLUSIONS: TTO values become more extreme with increasing experience. Because of the randomized valuation order, these effects do not bias specific health states; however, they reduce the overall validity and reliability of TTO values. Copyright Â
© 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22433766     DOI: 10.1016/j.jval.2011.10.010

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  7 in total

1.  Time to tweak the TTO: results from a comparison of alternative specifications of the TTO.

Authors:  Matthijs M Versteegh; Arthur E Attema; Mark Oppe; Nancy J Devlin; Elly A Stolk
Journal:  Eur J Health Econ       Date:  2013-07

2.  Learning and satisficing: an analysis of sequence effects in health valuation.

Authors:  Benjamin M Craig; Shannon K Runge; Kim Rand-Hendriksen; Juan Manuel Ramos-Goñi; Mark Oppe
Journal:  Value Health       Date:  2015-02-02       Impact factor: 5.725

3.  Time trade-off: one methodology, different methods.

Authors:  Arthur E Attema; Yvette Edelaar-Peeters; Matthijs M Versteegh; Elly A Stolk
Journal:  Eur J Health Econ       Date:  2013-07

4.  Study protocol for valuing EQ-5D-3L and EORTC-8D health states in a representative population sample in Sri Lanka.

Authors:  Sanjeewa Kularatna; Jennifer A Whitty; Newell W Johnson; Paul A Scuffham
Journal:  Health Qual Life Outcomes       Date:  2013-09-02       Impact factor: 3.186

5.  Influenced from the start: anchoring bias in time trade-off valuations.

Authors:  Liv Ariane Augestad; Knut Stavem; Ivar Sønbø Kristiansen; Carl Haakon Samuelsen; Kim Rand-Hendriksen
Journal:  Qual Life Res       Date:  2016-03-26       Impact factor: 4.147

6.  Impact of Including Carer Information in Time Trade-Off Tasks: Results from a Pilot Study.

Authors:  David J Mott; Iain Leslie; Koonal Shah; Jennifer Rowell; Nicolas Scheuer
Journal:  Pharmacoecon Open       Date:  2021-05-09

7.  A comparison of individual and collective decision making for standard gamble and time trade-off.

Authors:  Arthur E Attema; Han Bleichrodt; Olivier l'Haridon; Stefan A Lipman
Journal:  Eur J Health Econ       Date:  2020-01-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.